Yazar "Capar, S." için listeleme

Toplam kayıt 1, listelenen: 1-1

Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis

Uslu, S.; Gülle, S.; Sen, G.; Capar, S.; Senel, S.; Dalkılıc, E.; Akar, S. (Multidisciplinary Digital Publishing Institute (MDPI), 2024)

Background/Objectives: CT-P13 is a biosimilar version of infliximab, a monoclonal antibody. In individuals with ankylosing spondylitis (AS), CT-P13 has been shown to be effective and to have a well-tolerated safety profile. ...